Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Format:	Article
Language:	English
Published:	Karger Publishers 2012-02-01
Subjects:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
Online Access:	http://www.karger.com/Article/FullText/337022